Neuland Laboratories (BOM:524558) 3-Year EBITDA Growth Rate : 44.40% (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Neuland Laboratories 3-Year EBITDA Growth Rate?

Neuland Laboratories's EBITDA per Share for the three months ended in Mar. 2024 was ₹87.51.

During the past 12 months, Neuland Laboratories's average EBITDA Per Share Growth Rate was 68.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 44.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 47.40% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 13.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Neuland Laboratories was 44.40% per year. The lowest was -18.60% per year. And the median was 4.70% per year.

Competitive Comparison of Neuland Laboratories's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Neuland Laboratories's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neuland Laboratories's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neuland Laboratories's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Neuland Laboratories's 3-Year EBITDA Growth Rate falls into.

Neuland Laboratories 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Neuland Laboratories (BOM:524558) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Neuland Laboratories 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Neuland Laboratories's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuland Laboratories (BOM:524558) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neuland Laboratories Ltd (BOM:524558) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

NEULANDLAB:India

Address

Road No. 82, Jubilee Hills, Plot No. 573A-III, Phoenix IVY Building, 11th Floor (5th Office Level), Hyderabad, TG, IND, 500033

Website

https://www.neulandlabs.com

Neuland Laboratories Ltd is a manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry's chemistry needs in Hyderabad. Geographically, it derives a majority of revenue from North America and also has a presence in India, Europe, and Rest of the world.

Neuland Laboratories (BOM:524558) Headlines

No Headlines